MDGS - Medigus Ltd.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 59.08M
Enterprise Value 3-1.47M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)20.82
Price/Book (mrq)1.16
Enterprise Value/Revenue 3-3.37
Enterprise Value/EBITDA 60.22

Trading Information

Stock Price History

Beta (3Y Monthly) 1.92
52-Week Change 3-23.55%
S&P500 52-Week Change 36.34%
52 Week High 33.8400
52 Week Low 32.1100
50-Day Moving Average 32.3833
200-Day Moving Average 32.6989

Share Statistics

Avg Vol (3 month) 3111.49k
Avg Vol (10 day) 3129.03k
Shares Outstanding 53.8M
Float 3.77M
% Held by Insiders 16.04%
% Held by Institutions 110.91%
Shares Short (Jun 28, 2019) 415.83k
Short Ratio (Jun 28, 2019) 40.17
Short % of Float (Jun 28, 2019) 4N/A
Short % of Shares Outstanding (Jun 28, 2019) 40.12%
Shares Short (prior month May 31, 2019) 414.94k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 24/1
Last Split Date 3Jul 16, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,530.28%

Management Effectiveness

Return on Assets (ttm)-45.21%
Return on Equity (ttm)-97.10%

Income Statement

Revenue (ttm)436k
Revenue Per Share (ttm)0.20
Quarterly Revenue Growth (yoy)-36.40%
Gross Profit (ttm)-171k
EBITDA -6.63M
Net Income Avi to Common (ttm)-6.6M
Diluted EPS (ttm)-3.2000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.62M
Total Cash Per Share (mrq)2.8
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.18
Book Value Per Share (mrq)2.12

Cash Flow Statement

Operating Cash Flow (ttm)-4.22M
Levered Free Cash Flow (ttm)-3.63M